Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical considerations in screening for genetic alterations in cholangiocarcinoma
Tanios Bekaii‐Saab, John Bridgewater, Nicola Normanno
Annals of Oncology (2021) Vol. 32, Iss. 9, pp. 1111-1126
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 132
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 92
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 36, pp. 5569-5578
Open Access | Times Cited: 52
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe
Lorenza Rimassa, Ángela Lamarca, Grainne M. O’Kane, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101170-101170
Open Access | Times Cited: 2
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
Simon Rushbrook, Timothy J. Kendall, Yoh Zen, et al.
Gut (2023) Vol. 73, Iss. 1, pp. 16-46
Open Access | Times Cited: 28
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types
Pashtoon Murtaza Kasi, Jessica Lee, Lincoln W. Pasquina, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 836-848
Open Access | Times Cited: 23
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4189-4189
Open Access | Times Cited: 13
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies
Alessandro Parisi, Blandine Delaunay, Giada Pinterpe, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113587-113587
Open Access | Times Cited: 10
Liquid Biopsy in the Clinical Management of Cancers
Ho-Yin Ho, Kei-See Chung, Chau-Ming Kan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8594-8594
Open Access | Times Cited: 10
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 19
CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma
Wenwei Liao, Jinpeng Du, Lian Li, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 17
Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
Maria Consiglia Bragazzi, Rosanna Venere, Emanuela Ribichini, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 3, pp. 383-393
Closed Access | Times Cited: 17
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C. Benedikt Westphalen, et al.
European Journal of Cancer (2024) Vol. 203, pp. 114046-114046
Open Access | Times Cited: 8
Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper
Matteo Fassan, Valentina Angerilli, Nicola Normanno, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104224-104224
Open Access | Times Cited: 7
Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know
Carmen Cutolo, Federica Dell’Aversana, Roberta Fusco, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 890-890
Open Access | Times Cited: 25
Role of molecular genetics in the clinical management of cholangiocarcinoma
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 25
Progression-Free Survival in Patients With Cholangiocarcinoma With or Without FGF/FGFR Alterations: A FIGHT-202 Post Hoc Analysis of Prior Systemic Therapy Response
Kristen Bibeau, Luis Féliz, Christine Lihou, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 24
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
Mina Komuta
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 396-407
Open Access | Times Cited: 23
Circular RNAs in cholangiocarcinoma
Wenwei Liao, Qingbo Feng, Huixian Liu, et al.
Cancer Letters (2022) Vol. 553, pp. 215980-215980
Closed Access | Times Cited: 23
Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine
Purva Gopal, Marie E. Robert, Xuchen Zhang
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 3, pp. 359-370
Open Access | Times Cited: 16
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
Svetlana N. Aleksakhina, Evgeny N. Imyanitov
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10931-10931
Open Access | Times Cited: 31
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jiafeng Chen, Xiaogang Li, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
Davide Ciardiello, Brigida Anna Maiorano, Paola Parente, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 820-820
Open Access | Times Cited: 21
Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
Woo Jin Choi, Tommy Ivanics, Annabel Gravely, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3849-3863
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top